异动解读｜安捷伦科技盘中上涨5.12%，完成收购Biocare Medical加码临床诊断

行情直击06-25

6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。

消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在数字化病理学平台及高精度癌症染色诊断领域迈出关键一步。

此外，近期多重利好叠加支撑股价：巴克莱将目标价从145美元上调至150美元并维持跑赢大盘评级；公司此前第二财季调整后EPS为1.49美元，超市场预期的1.41美元，营收18.4亿美元亦超预期，同时上调全年指引至EPS 6.00-6.10美元。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1120154567?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-25 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120154567","market":"hk","top_or_hot":-1,"title":"异动解读｜安捷伦科技盘中上涨5.12%，完成收购Biocare Medical加码临床诊断","media":"行情直击","content":"<p><p>6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。</p><p>消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在数字化病理学平台及高精度癌症染色诊断领域迈出关键一步。</p><p>此外，近期多重利好叠加支撑股价：巴克莱将目标价从145美元上调至150美元并维持跑赢大盘评级；公司此前第二财季调整后EPS为1.49美元，超市场预期的1.41美元，营收18.4亿美元亦超预期，同时上调全年指引至EPS 6.00-6.10美元。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜安捷伦科技盘中上涨5.12%，完成收购Biocare Medical加码临床诊断</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜安捷伦科技盘中上涨5.12%，完成收购Biocare Medical加码临床诊断\n</h2>\n\n<h4 class=\"meta\">\n\n2026-06-25 22:37 北京时间&nbsp;&nbsp;&nbsp;<strong>行情直击</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"A","symbol_name":"安捷伦科技","start_time":0,"source_url":"","article_id":"1120154567","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120154567","pubTimestamp":1782398233,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在数字化病理学平台及高精度癌症染色诊断领域迈出关键一步。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"A":"安捷伦科技"},"translate_title":"Interpretation of the change | Agilent Technologies rose 5.12% intraday, completing the acquisition of Biocare Medical to increase clinical diagnosis","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"A":1},"content_text":"6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在数字化病理学平台及高精度癌症染色诊断领域迈出关键一步。此外，近期多重利好叠加支撑股价：巴克莱将目标价从145美元上调至150美元并维持跑赢大盘评级；公司此前第二财季调整后EPS为1.49美元，超市场预期的1.41美元，营收18.4亿美元亦超预期，同时上调全年指引至EPS 6.00-6.10美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120154567","isCrawlerRequest":true}